CLPS Authorization of $100M Share Repurchase Program

The board of Clinical and Laboratory Physics Solutions (CLPS:NYSE) authorized a $100 million share repurchase program on February 4, 2026. The initiative, effective immediately, allows the company to reduce its share count and potentially boost shareholder value through stock buybacks. The program is subject to board approval and available shares, with no specific expiration date. CLPS plans to use the program to enhance capital structure and return value to shareholders, reflecting confidence in its future cash flows and balance sheet strength.